Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引:28
|
作者
Tilly, H. [1 ]
Dreyling, M. [2 ]
机构
[1] Ctr Henry Becquerel, Dept Hematol, Rouen, France
[2] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Med 3, Munich, Germany
关键词
CHEMOTHERAPY PLUS RITUXIMAB; RANDOMIZED CONTROLLED-TRIAL; ELDERLY-PATIENTS; CHOP CHEMOTHERAPY; TRANSPLANTATION; THERAPY;
D O I
10.1093/annonc/mdp145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:110 / 112
页数:3
相关论文
共 50 条
  • [21] Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Pacini, F.
    Castagna, M. G.
    Brilli, L.
    Pentheroudakis, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 143 - 146
  • [22] Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Van Cutsem, E.
    Oliveira, J.
    ANNALS OF ONCOLOGY, 2009, 20 : 61 - 63
  • [23] Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Baccarani, M.
    Dreyling, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 105 - 107
  • [24] Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Kataja, V.
    Castiglione, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 10 - 14
  • [25] Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma
    Wei, Xiaolei
    Wei, Yongqiang
    Huang, Fen
    Jing, Hui
    Xie, Muchen
    Hao, Xiaoxiao
    Feng, Ru
    LEUKEMIA & LYMPHOMA, 2015, 56 (05) : 1261 - 1265
  • [26] A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma
    Gao, Guanghui
    Liang, Xiaohua
    Jiang, Jingwei
    Zhou, Xinli
    Huang, Ruofan
    Chu, Zhaohui
    Zhan, Qiong
    ACTA ONCOLOGICA, 2010, 49 (01) : 3 - 12
  • [27] Chronic lymphocytic leukemia: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up
    Eichhorst, B.
    Hallek, M.
    Dreyling, M.
    ANNALS OF ONCOLOGY, 2009, 20 : 102 - 104
  • [28] Molecular heterogeneity in diffuse large B-cell lymphoma and its implications in clinical diagnosis and treatment
    Guo, Lingchuan
    Lin, Pei
    Xiong, Hui
    Tu, Shichun
    Chen, Gang
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2018, 1869 (02): : 85 - 96
  • [29] Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients
    Li, Cong
    Lu, Fangxiao
    Lei, Tao
    Yu, Haifeng
    Yang, Haiyan
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5139 - 5146
  • [30] Diffuse Large B-Cell Lymphoma: Current Treatment Approaches
    Nastoupil, Loretta J.
    Rose, Adam C.
    Flowers, Christopher R.
    ONCOLOGY-NEW YORK, 2012, 26 (05): : 488 - 495